{
  "ptid_time": "094_S_2216_2011-04-28",
  "img_path": "/data/qiuhui/data/adni/images/094_S_2216/2011-04-28/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 57,111 mm³, 90.2% above the reference mean. With a Z-score of 2.14 (98.4th percentile), this represents significant enlargement; hippocampal volume measures 7,074 mm³, 11.9% below the reference mean. With a Z-score of -1.19 (11.8th percentile), this represents mild atrophy; whole brain volume measures 1,272,720 mm³, 12.2% above the reference mean. With a Z-score of 1.72 (95.8th percentile), this represents moderate enlargement; entorhinal cortex volume measures 4,790 mm³, 12.4% above the reference mean. With a Z-score of 0.86 (80.4th percentile), this represents normal volume ; fusiform gyrus volume measures 18,251 mm³, 8.3% below the reference mean. With a Z-score of -0.69 (24.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,814 mm³, 7.1% below the reference mean. With a Z-score of -0.59 (27.9th percentile), this represents normal volume . ",
  "text_data": "Age is 68.1 years. Gender is Male. Education: 14 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Musculoskeletal; Hematopoietic-Lymphatic; Smoking. MMSE: 27.0. MoCA: 22.0. Logical Memory: 9.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.32 SUVR (moderate elevated); Amyloid beta: 530.00 pg/mL (mild reduced); Total tau: 234.00 pg/mL (normal ); Phosphorylated tau: 23.14 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (suggesting brain atrophy) and mild hippocampal atrophy, both of which are associated with Alzheimer's disease. The MoCA score of 22 indicates mild cognitive impairment (MCI), while the MMSE of 27 is borderline normal. Elevated AV45 (amyloid PET) and mildly reduced Aβ (CSF) support amyloid pathology.  \n\n**Diagnosis:** **MCI (likely due to Alzheimer’s pathology)**  \n**Confidence:** **Medium** (due to borderline MMSE and lack of severe cognitive decline, but strong biomarker support for early AD progression)",
  "timestamp": "2025-07-26T10:25:53.714229"
}